Abstract
Drugs that have predominant CNS stimulant actions with few drugs possessing additional cognition enhancing effect are discussed in this chapter. There are three important groups of drugs in this category such as cognition enhancers, psychostimulants, and psychedelic drugs which possess overlapping pharmacological actions as well as actions unique to their respective group by altering the CNS functions. Cognition enhancers mainly have effect on the memory, improving wakefulness, and improving energy levels. Psychostimulants act by improving mental function, behaviour, increase motor activity, and reduce the feeling of fatigue. Psychedelic drugs mainly affect perception and thinking pattern in a complex way. Majority of these drugs do not possess any important medicinal value except a few. These drugs are recognised and studied only for their abusive potential and for recreational purposes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Bogenschutz MP, Ross S (2018) Therapeutic applications of classic hallucinogens. Curr Top Behav Neurosci 36:361–391
Busardò FP, Kyriakou C, Cipolloni L, Zaami S, Frati P (2016) From clinical application to cognitive enhancement: the example of methylphenidate. Curr Neuropharmacol 14:17–27
Carhart-Harris RL, Goodwin GM (2017) The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 42:2105–2113
Ferré S (2016) Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. Psychopharmacology 233:1963–1979
Liechti ME (2017) Modern clinical research on LSD. Neuropsychopharmacology 42:2114–2127
Lüscher C (2013) Drugs of abuse. In: Katzung BG, Trevor AJ (eds) Basic & clinical pharmacology, 13th edn. McGraw-Hill, New York, pp 552–566
O’Brien CP (2011) Drug addiction. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman and Gilman’s pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York, pp 649–668
Schrot RJ, Cannabinoids HJR (2016) Medical implications. Ann Med 4:128–141
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ananthy, V. (2021). Cognition Enhancers, Psychostimulants, and Psychedelic Drugs. In: Paul, A., Anandabaskar, N., Mathaiyan, J., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-33-6009-9_13
Download citation
DOI: https://doi.org/10.1007/978-981-33-6009-9_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6008-2
Online ISBN: 978-981-33-6009-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)